Nobilis Health Corp (NYSEAMERICAN:HLTH) (TSE:NHC) was the target of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 687,875 shares, a decrease of 11.0% from the January 15th total of 773,081 shares. Based on an average daily trading volume, of 95,703 shares, the short-interest ratio is currently 7.2 days. Currently, 1.2% of the shares of the company are short sold.
Separately, Benchmark raised shares of Nobilis Health from a “hold” rating to a “speculative buy” rating and set a $2.00 target price for the company in a report on Thursday, January 3rd.
An institutional investor recently bought a new position in Nobilis Health stock. Weber Alan W bought a new stake in shares of Nobilis Health Corp (NYSEAMERICAN:HLTH) (TSE:NHC) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 490,721 shares of the healthcare company’s stock, valued at approximately $491,000. Weber Alan W owned about 0.63% of Nobilis Health at the end of the most recent quarter.
Shares of HLTH stock opened at $0.35 on Tuesday. Nobilis Health has a 12 month low of $0.17 and a 12 month high of $1.70.
WARNING: This piece of content was reported by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2019/02/12/nobilis-health-corp-hlth-short-interest-down-11-0-in-january.html.
Nobilis Health Company Profile
Nobilis Health Corp. owns and manages ambulatory surgical centers (ASCs), and acute-care and surgical hospitals in the United States. It operates through two segments, Medical Services and Marketing. The company's healthcare facilities provides surgical procedures in various clinical specialties, including orthopedic surgery, podiatric, vein and vascular, pain management, gastro- intestinal, gynecology, and general, as well as ear, nose, and throat.
See Also: Should You Consider an Index Fund?
Receive News & Ratings for Nobilis Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nobilis Health and related companies with MarketBeat.com's FREE daily email newsletter.